NIH Funding · FY2024
Total Funding
$1.1M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#13,685
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $1.1M across 2 grants · National rank #13685.
Top grants by award amount
Michael Arthur Bruckman's NIH grant portfolio, ranked by award amount.
- 5R44HL145948-03R44SynthoPlate: Intravenous Hemostatic Nanotechnology to Mitigate Bleeding in Thrombocytopenia$972.2Kaward amount
- 3R44HL145948-03S1R44SynthoPlate: Intravenous Hemostatic Nanotechnology to Mitigate Bleeding in Thrombocytopenia$112.8Kaward amount
Affiliation
Institutions that have administered grants for Michael Arthur Bruckman.
Affiliated with Haima Therapeutics, LLC (OH).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardHaima Therapeutics, LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
Explore further
Find collaborators for Michael Arthur Bruckman
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Haima Therapeutics, LLC
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →